Home / Biosimilars

Biosimilars

News

Stada in-licenses teriparatide biosimilar posted 20/10/2014

German generics giant Stada Arzneimittel (Stada) announced on 13 October 2014 that it had made a deal to in-licensing a terip...

Merck KGaA plans further investment in biosimilars posted 20/10/2014

German pharma giant Merck KGaA announced on 18 September 2014 plans to step up investments in biosimilars during 2015.

Epirus and Livzon collaborate on copy biologicals for China posted 20/10/2014

US-based Epirus Biopharmaceuticals (Epirus) announced on 25 September 2014 that it had signed a collaboration agreement with...

Infliximab ‘similar biologic’ receives Indian approval posted 20/10/2014

US-based biologicals company Epirus Biopharmaceuticals (Epirus) announced on 15 September 2014 that it had received final mar...

Mylan starts phase III trials for biosimilar insulin glargine posted 20/10/2014

Generics maker Mylan has started two US phase III clinical trials for a biosimilar version of French drugmaker Sanofi’s diabe...

 

Research

Mobilization of stem cells by biosimilar Nivestim and Neupogen posted 20/10/2014

Comparison of biosimilar granulocyte colony-stimulating factor (G-CSF), Nivestim and originator G-CSF, Neupogen (filgrastim),...

Phase III study of biosimilar adalimumab meets primary endpoint posted 10/10/2014

Biologicals major Amgen announced on 8 October 2014 the first late-stage data from its biosimilars programme. Primary efficac...

Strategy for biosimilars in China posted 06/10/2014

China is one of the largest pharmaceutical markets in the world, and has seen rapid growth in the biopharmaceuticals industry...

Patient access to rituximab in emerging markets posted 06/10/2014

A Pfizer-sponsored study looking at access to the oncology treatment rituximab has revealed that use of this important drug w...

Regulating the safety of biosimilars posted 06/10/2014

Clinical safety is critically important during the development of a biosimilar. An overview of the main aspects of safety ass...

 

General

Biosimilars of epoetin alfa posted 22/10/2014

Last update: 17 October 2014Epoetin alfa is a human erythropoietin produced in cell culture using recombinant DNA technology....

IAPO releases toolkit for biologicals and biosimilars posted 20/10/2014

The International Alliance of Patients’ Organizations (IAPO), which comprises over 200 patient groups and represents the inte...

Biosimilars of adalimumab posted 20/10/2014

Adalimumab is a human monoclonal antibody that treats autoimmune diseases by inhibiting tumour necrosis factor (TNF); a solub...

Call for action on labelling of biosimilars posted 20/10/2014

European trade association, the European Association for Bioindustry (EuropaBio) has called on the European Medicines Agency...

Biosimilars applications under review by EMA – August 2014 posted 20/10/2014

The European Medicines Agency (EMA) is the body responsible for approval of biosimilars within the European Union (EU). A leg...

Generics News Research General

more

Biosimilars News Research General

more